Armistice Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-956,000
Closed -$17.5M 401
2024
Q1
$17.5M Sell
956,000
-812,000
-46% -$12.9M 0.23% 74
2023
Q4
$21.7M Buy
+1,768,000
New +$16.6M 0.3% 56
2021
Q2
Sell
-150,000
Closed -$7.6M 146
2021
Q1
$7.6M Buy
+150,000
New +$8.34M 0.17% 84

Other funds holding SILK

Armistice Capital's SILK Position: Q2 2024 in Review

Armistice Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 956,000 shares — an estimated $17.5M sold.

Armistice Capital first reported a position in SILK in Q1 2021 and held it in 3 quarters. The position peaked at $21.7M in Q4 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Armistice Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 956,000 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $17.5M.
  • Armistice Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Armistice Capital's Silk Road Medical, Inc. Common Stock position peaked at $21.7M in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.